Patents by Inventor Mutsuyuki Kochi

Mutsuyuki Kochi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Malignant cell differentiation inducer compositions and utilization of the same
    Publication number: 20040254123
    Abstract: The present invention relates to a differentiation inducer composition for inducing differentiation of malignant cells, characterized by comprising mono-sodium 5,6-O-benzylidene-L-ascorbate (SBA) as an active ingredient, and a pharmaceutically acceptable carrier; and a use thereof. SBA is useful as a novel differentiation inducing agent showing an excellent differentiation inducing action and having extremely low toxicity.
    Type: Application
    Filed: April 6, 2004
    Publication date: December 16, 2004
    Inventor: Mutsuyuki Kochi
  • Composition and method of treating selected malignant conditions
    Patent number: 4983636
    Abstract: As a result of research work and investigations relating to the effect of benzaldehyde on cell membranes, it was found that benzaldehyde has high activity in the treatment of selected malignant conditions. Based on this finding, we have now completed the present invention directed to a composition comprising benzaldehyde as the active ingredient. This composition is effective against selected malignant conditions which are carcinoma of the colon, cancer of the stomach, cancer of the tongue, peritonitis carcinomatosa, cancer of the liver and malignancies induced by SF.sub.40 virus.
    Type: Grant
    Filed: October 31, 1988
    Date of Patent: January 8, 1991
    Assignees: Rikagaku Kenkyusho Wako, Mutsuyuki Kochi
    Inventors: Setsuo Takeuchi, Mutsuyuki Kochi
  • A composition and method of treating selected malignant conditions
    Patent number: 4882314
    Abstract: Disclosed is a novel carcinostatic composition comprising 4,6-0-benzylidene-D-glucopyranose as the active ingredient. This active ingredient exerts a very high carcinostatic activity according to a specific carcinostatic mechanism quite different from that of conventional carcinostatic chemotherapeutic agents. The active ingredient is very low in toxicity and is highly stable and water-soluble. This composition is effective against selected malignant conditions which are carcinoma of the colon, cancer of the stomach, cancer of the tongue, peritonitis carcinomatosa, cancer of the liver and malignancies induced by SV.sub.40 virus.
    Type: Grant
    Filed: August 4, 1987
    Date of Patent: November 21, 1989
    Assignees: Rikagaku Kenkyusho, Mutsuyuki Kochi, Kaken Kagaku Kabushiki Kaisha
    Inventors: Setsuo Takeuchi, Mutsuyuki Kochi, Akira Kawarada, Shinichiro Esumi, Kaguya Sasaki, Shozo Kawabata, Tsuneo Saita, Yukio Inoue, Makoto Yamamoto, Keiji Sekine
  • Pharmaceutical composition for retarding and reducing cachexia
    Patent number: 4778785
    Abstract: A pharmaceutical composition for retarding and reducing cachexia comprising, as an efficacious ingredient, at least one compound selected from the group consisting of benzaldehyde and 4,6-O-benzylidene-D-glucose, and a method for retarding and reducing cachexia in humans which comprises administering to an affected human at least one said compound.
    Type: Grant
    Filed: August 29, 1986
    Date of Patent: October 18, 1988
    Assignees: Kaken Pharmaceutical Co., Ltd., Rikagaku Kenkyusho
    Inventors: Mutsuyuki Kochi, Shinichiro Esumi, Setsuo Takeuchi